RT @NatureOutlook: Most drug candidates go nowhere. And because of secrecy between pharma competitors, they do so over and over again https…
RT @NatureOutlook: Most drug candidates go nowhere. And because of secrecy between pharma competitors, they do so over and over again…
RT @NatureOutlook: Most drug candidates go nowhere. And because of secrecy between pharma competitors, they do so over and over again…
RT @NatureOutlook: Most drug candidates go nowhere. And because of secrecy between pharma competitors, they do so over and over again…
Most drug candidates go nowhere. And because of secrecy between pharma competitors, they do so over and over again https://t.co/NF0aH0GzQe https://t.co/yxAeOu6LrR
RT @NatureOutlook: Early stage cooperation among pharma rivals is improving drug discovery. @neilsavagewrite https://t.co/NF0aH0oYrE https…
Early stage cooperation among pharma rivals is improving drug discovery. @neilsavagewrite https://t.co/NF0aH0oYrE https://t.co/Sba9iMzUgr
Can pre-competitive partnerships avoid drug discovery's blind alleys?@neilsavagewrite. https://t.co/NF0aH0oYrE. https://t.co/tQ5092ZELq
RT @NatureOutlook: How #openinnovation is improving drug development, by @neilsavagewrite. https://t.co/NF0aH0oYrE https://t.co/uynzIkMgeX
Competition: Unlikely partnerships Greater openness could reduce redundancy and save money. https://t.co/gL1JplsdUs
RT @NatureOutlook: How #openinnovation is improving drug development, by @neilsavagewrite. https://t.co/NF0aH0oYrE https://t.co/uynzIkMgeX
RT @NatureOutlook: How #openinnovation is improving drug development, by @neilsavagewrite. https://t.co/NF0aH0oYrE https://t.co/uynzIkMgeX
RT @NatureOutlook: How #openinnovation is improving drug development, by @neilsavagewrite. https://t.co/NF0aH0oYrE https://t.co/uynzIkMgeX
RT @NatureOutlook: How #openinnovation is improving drug development, by @neilsavagewrite. https://t.co/NF0aH0oYrE https://t.co/uynzIkMgeX
How #openinnovation is improving drug development, by @neilsavagewrite. https://t.co/NF0aH0oYrE https://t.co/uynzIkMgeX
Competition: Unlikely partnerships https://t.co/fVm9yZRmIG
RT @uoftmedicine: .@NatureOutlook talks about how #openscience can accelerate biomedical research, highlighting @thesgconline https://t.co/…
RT @uoftmedicine: .@NatureOutlook talks about how #openscience can accelerate biomedical research, highlighting @thesgconline https://t.co/…
.@NatureOutlook talks about how #openscience can accelerate biomedical research, highlighting @thesgconline https://t.co/L6PtBhJdTD
RT @mrcppu: “I think this is going to become pretty big” says Philip Cohen: https://t.co/i2bdDO2rUL #ubiquitin #cancer #neurodegeneration #…
RT @mrcppu: “I think this is going to become pretty big” says Philip Cohen: https://t.co/i2bdDO2rUL #ubiquitin #cancer #neurodegeneration #…
RT @mrcppu: “I think this is going to become pretty big” says Philip Cohen: https://t.co/i2bdDO2rUL #ubiquitin #cancer #neurodegeneration #…
RT @mrcppu: “I think this is going to become pretty big” says Philip Cohen: https://t.co/i2bdDO2rUL #ubiquitin #cancer #neurodegeneration #…
RT @mrcppu: “I think this is going to become pretty big” says Philip Cohen: https://t.co/i2bdDO2rUL #ubiquitin #cancer #neurodegeneration #…
RT @mrcppu: “I think this is going to become pretty big” says Philip Cohen: https://t.co/i2bdDO2rUL #ubiquitin #cancer #neurodegeneration #…
“I think this is going to become pretty big” says Philip Cohen: https://t.co/i2bdDO2rUL #ubiquitin #cancer #neurodegeneration #Dundee #DSTT
Openness leads to faster science--importance for drug development https://t.co/te9oo0nE1k
Interesting reading .... Competition: Unlikely partnerships https://t.co/s4G4XXb6Mj
Competition: Unlikely partnerships https://t.co/5hhwcAOLps
Competition: Unlikely partnerships https://t.co/9H9BXEJjfs
Competition: Unlikely partnerships https://t.co/j5MLDKQlLh
Competition: Unlikely partnerships https://t.co/VH1gDUSo0V
Competition: Unlikely partnerships: https://t.co/79TodWA9t5
Competition: Unlikely partnerships https://t.co/7AWbS6vkze
Competition: Unlikely partnerships https://t.co/3KE6Nio6aC
Competition: Unlikely partnerships https://t.co/HCzXNk9Cwv